Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by rome1on May 18, 2010 8:35pm
583 Views
Post# 17111560

Bizzare Posts Today

Bizzare Posts Today
I would not put too much emphasis on that post by Rinny or what ever his name is.

Every one is nervous....I get it, but at this point you are either in or you are out. The news is coming.....boom or bust ,but as of today if you are still invested....you obviously want to find out, one way or another.

Chloe is on mat leave and the girl covering her position is Angelica ( I believe that is her name )....so this Rinny character is talking about her?.....sure.

I have talked to them constantly for over a year and believe the results are going to be positive with the limited information at hand...you either believe or you don't....but at this point I am not willing to walk away without knowing.

Time will tell and it won't be much longer now!

Good luck.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse